Impact of a Genomic Test on Treatment Decision in a Predominantly African American Population With Favorable-Risk Prostate Cancer: A Randomized Trial
CONCLUSION: In contrast to other studies, the net effect of the GPS was to move patients away from AS, primarily among men with low health literacy. These findings have implications for our understanding of how prognostic molecular assays that generate probabilities of poor outcome can affect treatment decisions in diverse clinical populations.PMID:33835822 | DOI:10.1200/JCO.20.02997
Source: Clinical Prostate Cancer - Category: Cancer & Oncology Authors: Adam B Murphy Michael R Abern Li Liu Heidy Wang Courtney M P Hollowell Roohollah Sharifi Patricia Vidal Andre Kajdacsy-Balla Marin Sekosan Karen Ferrer Shoujin Wu Marlene Gallegos Patrice King-Lee Lisa K Sharp Carol E Ferrans Peter H Gann Source Type: research
More News: Cancer | Cancer & Oncology | Genetics | Graduation | Health Insurance | Insurance | Prostate Cancer | Study